Details of the Drug
General Information of Drug (ID: DMVKU4L)
| Drug Name |
4-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-chloro-N-(4-phenyl-1,3-thiazol-2-yl)benzamide; CHEMBL62078; 4-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide; 103966-00-3; (Z)-4-chloro-N-(4-phenylthiazol-2(3H)-ylidene)benzamide; AC1LF4A9; Oprea1_546006; SCHEMBL17107148; MolPort-000-422-245; MolPort-003-009-218; CCG-1056; ZINC4693069; STK514420; BDBM50101787; AKOS024573977; AKOS000620846; MCULE-1729549249; BAS 00444248; ST45229639; N-(4-Phenyl-2-thiazolyl)-4-chlorobenzamide; AH-034/06884044; SR-01000394981; SR-01000394981-1; F0013-0438
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 314.8 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 4.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


